한글목차

뼈 성장 자극기 세계 시장 규모는 2024년에 12억 4,000만 달러로 평가되었습니다. 예측 기간 중 연평균 복합 성장률(CAGR)은 5.19%를 나타낼 전망이며, 2030년에는 16억 8,000만 달러에 이를 것으로 예측됩니다.

뼈 성장 촉진제 세계 시장은 노인 인구 증가와 전 세계적으로 뼈 질환과 함께 우발적인 부상이 증가하고 있는 것을 배경으로 큰 성장세를 보이고 있습니다. 또한, 관절염, 당뇨병 유사 질환, 비만, 혈관 질환, 신장 질환과 같은 다른 질환의 유병률 증가, 저침습적 및 비침습적 수술 치료에 대한 수요 증가는 수년 동안 시장 성장을 가속하는 주요 요인으로 작용했습니다. 또한, 골절 및 정형외과 질환의 치료를 위해 뼈 성장 자극제가 제공하는 뼈 성장 자극제 및 절차적 이점에 대한 인식이 높아짐에 따라 예측 기간 동안 시장 성장을 더욱 촉진할 것으로 예측됩니다.

시장 성장 촉진요인

뼈 질환 및 골절 발생률 증가

주요 시장 이슈

뼈 성장 촉진 장치 장치의 높은 비용

주요 시장 동향

웨어러블 기술과 스마트 기술의 통합

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 뼈 성장 자극기 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 유형별(외부 뼈 성장 자극기, 초음파 뼈 성장 자극기, 임플란트 뼈 성장 자극기)
  • 용도별(척추 고정술, 뼈 유합 지연 및 뼈 유합 부전 골절, 구강외과 및 악안면외과, 기타)
  • 최종사용자별(병원 및 외래수술센터(ASC), 홈케어 시설, 학술연구기관)
  • 지역별
  • 기업별(2024년)
• 시장 맵
  • 유형별
  • 용도별
  • 최종사용자별
  • 지역별

제6장 북미의 뼈 성장 자극기 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 뼈 성장 자극기 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 뼈 성장 자극기 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 뼈 성장 자극기 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 뼈 성장 자극기 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 진보
• 제품 출시
• 인수합병(M&A)

제13장 세계의 뼈성장 자극제 시장 : SWOT 분석

제14장 Porter의 Five Forces 분석

• 업계내 경쟁
• 신규 참여 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• Colfax Corporation
• Arthrex
• Essex Woodlands Healthcare Partners
• Isto Biologics
• Johnson and Johnson
• Medtronic Plc
• Orthofix Medical Inc.
• Stryker Corporation
• Terumo Corporation
• Zimmer Biomet Holdings

제16장 전략적 제안

제17장 회사 소개 및 면책조항

영문목차

Global Bone Growth Stimulator Market was valued at USD 1.24 billion in 2024 and is expected to reach USD 1.68 billion by 2030 with a CAGR of 5.19% during the forecast period. The global market for Bone Growth Stimulator is experiencing significant growth, driven by the growing geriatric population along with the increasing incidences of accidental injuries along with bone disorders across the globe. Additionally, the rising prevalence of arthritis, diabetes-like diseases, and other medical conditions like obesity, vascular diseases, renal disorder and increasing demand for minimally invasive and non-invasive surgical treatments are the major factors driving the growth of the market over the years. Additionally, growing awareness about bone growth stimulators and procedural benefits provided by bone growth stimulators for the treatment of bone fracture and orthopedic diseases is further boosting the market growth during the forecast period.

Key Market Drivers

Rising Incidence of Bone Disorders and Fractures

A key driver of the bone growth stimulator market is the global rise in the incidence of bone-related conditions, including fractures, osteoporosis, and spinal disorders. According to the World Health Organization (WHO), osteoporosis is estimated to affect more than 200 million people globally, with millions suffering fractures because of weakened bones. In the U.S. alone, the Centers for Disease Control and Prevention (CDC) reports over 8.9 million osteoporotic fractures annually. The aging population is a major contributor to this increase, with the United Nations projecting that the global population aged 65 and above will more than double from 761 million in 2021 to 1.6 billion by 2050. As bone healing tends to be slower in elderly individuals, the demand for non-invasive, supportive treatments like bone growth stimulators is growing. These devices, which use ultrasound or electrical pulses to stimulate natural bone regeneration, are increasingly adopted post-surgery and in complex fractures. Additionally, sports-related injuries in younger demographics have also contributed to the growing demand, with bone stimulators offering an effective adjunct therapy to speed up healing.

Key Market Challenges

High Cost of Bone Growth Stimulator Devices

Despite their clinical benefits, bone growth stimulators remain relatively expensive and are often not accessible to a wide segment of the population, particularly in low- and middle-income countries. The upfront cost of a single device can run into thousands of dollars, posing a financial barrier for patients without insurance or adequate healthcare coverage. Even in developed nations, many private insurers and national health services impose stringent guidelines for reimbursement, limiting patient access unless certain clinical criteria are met. According to Medicare guidelines in the U.S., coverage is generally limited to specific non-union fractures that haven't shown signs of healing after 90 days, excluding broader use cases such as preventive post-operative care. Additionally, the recurring costs associated with consumables, servicing, and clinician training further burden hospitals and healthcare providers. These cost-related barriers hinder widespread adoption, particularly in emerging markets where healthcare budgets are limited. Without broader reimbursement frameworks or subsidy programs, the penetration of these devices remains constrained despite clinical efficacy.

Key Market Trends

Integration of Wearable and Smart Technologies

A growing trend in the bone growth stimulator market is the incorporation of wearable and smart technology features into traditional stimulation devices. With increasing digitization in healthcare, next-generation stimulators are being developed with features such as Bluetooth connectivity, real-time treatment tracking, mobile app integration, and data analytics. These innovations help clinicians monitor patient compliance, treatment effectiveness, and adjust protocols remotely. In line with global efforts to promote home-based healthcare and reduce hospital remissions, such advancements improve both the convenience and outcomes of bone healing treatments. Governments and health authorities, including the European Commission's eHealth Action Plan, are increasingly supporting digital health innovations that reduce the burden on centralized health systems. By integrating sensors and AI-driven insights, companies are creating personalized therapy plans that align with the broader movement toward precision medicine. As wearable technologies become more affordable and user-friendly, their role in orthopedic rehabilitation is expected to expand significantly.

Key Market Players

• Colfax Corporation
• Arthrex
• Essex Woodlands Healthcare Partners
• Isto Biologics
• Johnson and Johnson
• Medtronic Plc
• Orthofix Medical Inc.
• Stryker Corporation
• Terumo Corporation
• Zimmer Biomet Holdings

Report Scope:

In this report, the Global Bone Growth Stimulator Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bone Growth Stimulator Market, By Type:

• External Bone Growth Stimulators
• Ultrasonic Bone Growth Stimulators
• Implanted Bone Growth Stimulators

Bone Growth Stimulator Market, By Application:

• Spinal Fusion Surgeries
• Delayed Union and Non-union Bone Fractures
• Oral and Maxillofacial Surgeries
• Others

Bone Growth Stimulator Market, By End User:

• Hospital and Ambulatory Surgery Centres
• Home Care Settings
• Academic and Research Institutes

Bone Growth Stimulator Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Bone Growth Stimulator Market.

Available Customizations:

Global Bone Growth Stimulator Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bone Growth Stimulator Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
  • 5.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
  • 5.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Type
  • 5.3.2. By Application
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Bone Growth Stimulator Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
  • 6.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
  • 6.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bone Growth Stimulator Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Bone Growth Stimulator Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Bone Growth Stimulator Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Bone Growth Stimulator Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
  • 7.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
  • 7.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Bone Growth Stimulator Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Bone Growth Stimulator Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Bone Growth Stimulator Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Bone Growth Stimulator Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Bone Growth Stimulator Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Bone Growth Stimulator Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
  • 8.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
  • 8.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Bone Growth Stimulator Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Bone Growth Stimulator Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Bone Growth Stimulator Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Bone Growth Stimulator Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Bone Growth Stimulator Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Bone Growth Stimulator Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
  • 9.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
  • 9.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Bone Growth Stimulator Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Bone Growth Stimulator Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Bone Growth Stimulator Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Bone Growth Stimulator Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
  • 10.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
  • 10.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Bone Growth Stimulator Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Bone Growth Stimulator Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Bone Growth Stimulator Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Advancements
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Bone Growth Stimulators Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Colfax Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Arthrex
• 15.3. Essex Woodlands Healthcare Partners
• 15.4. Isto Biologics
• 15.5. Johnson and Johnson
• 15.6. Medtronic Plc
• 15.7. Orthofix Medical Inc.
• 15.8. Stryker Corporation
• 15.9. Terumo Corporation
• 15.10. Zimmer Biomet Holdings

16. Strategic Recommendations

17. About Us & Disclaimer